MedPath

Pentetreotide

Generic Name
Pentetreotide
Drug Type
Small Molecule
Chemical Formula
C63H87N13O19S2
CAS Number
138661-02-6
Unique Ingredient Identifier
G083B71P98

Overview

Pentetreotide has been used in trials studying the diagnosis of Cushing's syndrome.

Indication

No indication information available.

Associated Conditions

  • Carcinoid Tumors
  • Gastroenteropancreatic Neuroendocrine Tumors

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
1999/11/04
Phase 2
Completed
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
OCTREOSCAN FOR INJECTION
SIN11244P
INJECTION, POWDER, FOR SOLUTION
10 mcg/vial (in vial B)
12/16/1999

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

© Copyright 2025. All Rights Reserved by MedPath